Description
GLP-3 R3T
Synthetic peptide tri-agonist for in vitro research of metabolic receptor pathways
Overview & Mechanism of Action (In Vitro)
GLP-3 R3T is a synthetic peptide compound developed for biochemical and pharmacological research. In laboratory models, it is investigated as a selective multi-target agonist with affinity for three distinct classes of G-protein coupled receptors (GPCRs):
- GLP-1 receptor (Glucagon-Like Peptide-1 receptor): Modulation of intracellular cascades associated with adenylate cyclase activation and cAMP synthesis stimulation.
- GIP receptor (Glucose-Dependent Insulinotropic Polypeptide receptor): Synergistic cellular interactions influencing carbohydrate and lipid signaling pathways.
- Glucagon receptor (GCGR): Investigation of binding dynamics in hepatic cell lines and its impact on energy homeostasis signaling.
The peptide backbone features an engineered amino acid sequence conjugated to a hydrophobic di-acid lipid moiety. In experimental environments, this structural modification enhances stability against proteolytic degradation by the DPP-4 enzyme (dipeptidyl peptidase-4) and provides an extended half-life during kinetic assays.
Technical & Chemical Specifications
- Classification: Research Peptide / Tri-Agonist (GLP-1R / GIPR / GCGR)
- Form: Sterile lyophilized white powder (cake)
- Molecular Weight Identification: Confirmed via Mass Spectrometry (MS)
- Recommended Reconstitution Solvent: Sterile bacteriostatic water or phosphate-buffered saline (PBS)
- Storage Conditions: Store long-term at -20 °C in a dry, dark environment. Following reconstitution, keep refrigerated at 2–8 °C and utilize within standard experimental protocol timelines.
Scientific References & Literature
- Coskun, T., et al. LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist: In vitro pharmacology and mechanism of action. Cell Metabolism, 2022.
- Jastreboff, A. M., et al. Triple-Hormone-Receptor Agonist Mechanisms in Metabolic Signaling Systems. The New England Journal of Medicine, 2023.
- Finan, B., et al. Chemical optimization and receptor selectivity profiles of multi-agonist peptide platforms. Nature Reviews Drug Discovery, 2020.
- Knerr, P. J., et al. Next-generation multi-receptor glucagon-family peptides: Structural insights and in vitro activity profiles. Bioorganic & Medicinal Chemistry, 2021.
Legal Disclaimer & Terms of Purchase
This product is classified and supplied strictly for laboratory, scientific, and in vitro research purposes only (Research Use Only – RUO). This compound is not a drug, medicine, dietary supplement, cosmetic product, or substance intended for human or veterinary consumption, direct administration, injection, or diagnostic procedures.
By placing an order, the purchaser explicitly confirms that they are at least 18 years of age, possess the requisite professional qualifications and laboratory equipment to safely handle research materials, and are fully conversant with all relevant safety protocols for managing research substances. The seller assumes no liability for any use contrary to these terms.




